NSE - SMEListed
Nidan Laboratories and Healthcare Limited
Company websiteNidan Laboratories and Healthcare Limited is launching an IPO sized at ₹40,00,000 crore. The raise comprises a fresh issue of ₹0 crore and an OFS of ₹0 crore, together representing roughly 1000 shares.
Subscription is open from 28-10-2021 to 02-11-2021. The allotment is expected on 09-11-2021, and listing is targeted for 12-11-2021. Note: fresh issue proceeds typically go to the company while OFS proceeds go to selling shareholders.
Start Date28-10-2021
End Date02-11-2021
Listing Date12-11-2021
Allotment Date09-11-2021
Current Price₹123.90
GMP₹0 (0.00%)
Lot Size1000 Shares
Subscription0 Times
Face Value₹10 per share
Listing atNSE
Issue Price₹125- ₹125
Pre Issue₹1,39,00,000
Post Issue₹2,00,000
Issue Size₹40,00,000
(aggregating up to 50.00 Cr)
(aggregating up to 50.00 Cr)
Fresh Issue
(aggregating up to 0.00 Cr)
(aggregating up to 0.00 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Nidan Laboratories and Healthcare Limited is currently around ₹0 (0.00%). This indicates an estimated listing price of approximately ₹125 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
10 Apr 2025, 09:15 | ₹125 | ₹0 | ₹125 (0.00%) |
Financials overview In Lakhs
Here is a quick look at the recent financial performance of Nidan Laboratories and Healthcare Limited . The numbers below ( In Lakhs ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
The IPO reservation for Nidan Laboratories and Healthcare Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
Market Maker | 5.00% | 2,00,000 |
NII (HNI) | 47.50% | 19,00,000 |
RETAIL | 47.50% | 19,00,000 |
TOTAL | 100.00% | 40,00,000 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 1,000 | ₹1,25,000 | |
HNI | 2 | 2,000 | ₹2,50,000 |
Below you can find the official contact details of Nidan Laboratories and Healthcare Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: cs@nidanhealthcare.co.in
Phone: +91 8975610000
Website: https://nidanhealthcare.co.in/
Address: Swapnshilpa, Behind Aarti Apartment, Vartak Road, Virar (West) – 401303, Palagar, Maharashtra, India